Nikhil Patel

Founder at Craniometrix, making Alzheimer’s suck less. Forbes 30u30. Prev @GoldmanSachs @Yale.

[Nikhil Patel @nikhillinit]

2/ It's truly astonishing to consider the immense size of the Alzheimer's care market compared to the number of founders attempting to innovate in this space.

[Nikhil Patel @nikhillinit]

4/9: When it seemed like the storm was at its fiercest, they invited former Merck & Co. CEO, Roy Vagelos, to steer their wavering ship. Vagelos, with wisdom and experience, introduced two pivotal strategies that served as a lighthouse for Regeneron.

[Nikhil Patel @nikhillinit]

3/9: The early journey was tough, filled with skepticism and failure. Their first two drugs – one aimed at Lou Gehrig's disease, the other at obesity – were failures. The fledgling company struggled to stay afloat, with recruitment and research efforts yielding no results.

[Nikhil Patel @nikhillinit]

5/ My big idea in those early days was a screening tool for Alzheimer’s.

Catching the disease early could lead to preemptive family care plans. But nothing came of it.

I abandoned bio for economics and computer science degrees at Yale.

[Nikhil Patel @nikhillinit]

4/ Three years of lab coats, experiments, and research into the mysterious degeneration I witnessed take place in my Grandma’s brain.

Doctors treat patients.
Entrepreneurs make sure that the treatment is accessible and deployable. I was to be the latter.